Publications
  1. Cost-utility analysis of high-dose treatment for intermediate-susceptible, dose-dependent tuberculosis patients

    Zuur, M. A., van Asselt, A. D. I., van 't Boveneind-Vrubleuskaya, N., Aleksa, A., Postma, M. J. & Alffenaar, J. W. C. 1-Sep-2018 In : International Journal of Tuberculosis and Lung Disease. 22, 9, p. 991-999 9 p.

    Research output: Contribution to journalArticle

  2. A report on the status of vaccination in Europe

    Sheikh, S., Biundo, E., Courcier, S., Damm, O., Launay, O., Maes, E., Marcos, C., Matthews, S., Meijer, C., Poscia, A., Postma, M., Saka, O., Szucs, T. & Begg, N. 9-Aug-2018 In : Vaccine. 36, 33, p. 4979-4992 14 p.

    Research output: Contribution to journalReview article

  3. The Impact of Patent Expiry on Drug Prices: A Systematic Literature Review

    Vondeling, G. T., Cao, Q., Postma, M. J. & Rozenbaum, M. H. 17-Jul-2018 In : Applied Health Economics and Health Policy. 8 p.

    Research output: Contribution to journalReview article

View all (723) »

Press / Media
  1. Hoe een veilig vaccin tegen Lyme het slachtoffer werd van slechte pr

    Maarten Postma

    22/04/2017

    1 item of media coverage

    Press/Media: Expert Comment

  2. Dagblad De Limburger: Lyme vaccine

    Maarten Postma

    22/03/2016

    1 item of media coverage

    Press/Media: Other

View all (10) »

Activities
  1. All Wales Medicines Strategy Group (AWMSG)

    Postma, M. (Advisor)
    2016 → …

    Activity: ProfessionalConsultancy

  2. Committee for Vaccination & Immunization (JVCI) (External organisation)

    Postma, M. (Member)
    2015 → …

    Activity: ProfessionalMembership of council

  3. ARTEG (External organisation)

    Postma, M. (Member)
    2015 → …

    Activity: ProfessionalMembership of council

View all (7) »

View graph of relations

ID: 193217